uniQure (QURE) Cash from Investing Activities (2016 - 2026)

uniQure (QURE) recorded quarterly Cash from Investing Activities of $98.6 million in Q1 2026, up 122.33% quarter-over-quarter from -$441.4 million in Q4 2025, and up 390.37% on a YoY basis from $20.1 million in Q1 2025.

uniQure (QURE) Cash from Investing Activities (2016 - 2026) Analysis & Trends

uniQure's Cash from Investing Activities history runs 11 years deep, the most recent figure standing at $98.6 million for Q1 2026.

  • In Q1 2026, Cash from Investing Activities rose 390.37% year-over-year to $98.6 million; the TTM figure through Mar 2026 stood at -$243.2 million (down 304.19% YoY), while the FY2025 annual figure was -$321.6 million, down 297.35% from the prior year.
  • Cash from Investing Activities was $98.6 million for Q1 2026 at uniQure, up from -$441.4 million in the prior quarter.
  • In the past five years, Cash from Investing Activities ranged from a high of $98.6 million in Q1 2026 to a low of -$441.4 million in Q4 2025.
  • Historically, Cash from Investing Activities has averaged -$26.4 million across 5 years, with a median of $20.1 million in 2025.
  • The sharpest annual moves came in 2023 and 2024: Cash from Investing Activities plunged 6103.16% in 2023, then soared 2041.4% in 2024.
  • A 5-year view of Cash from Investing Activities shows it stood at -$168.2 million in 2022, then soared by 135.41% to $59.6 million in 2023, then plunged by 144.7% to -$26.6 million in 2024, then slumped by 1557.79% to -$441.4 million in 2025, then surged by 122.33% to $98.6 million in 2026.
  • The last three Cash from Investing Activities figures came in at $98.6 million (Q1 2026), -$441.4 million (Q4 2025), and $26.6 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Investing Activities (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - -2.89 Mn
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn 638.50 Mn
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - -
7 Psyence Biomedical 212.16 Bn 212.16 Bn - -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn -431.90 Mn
9 Abivax 91.96 Bn 91.96 Bn - 579,519.10
10 uniQure 2.88 Bn 2.88 Bn 3.34 Mn 98.56 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 98.56 Mn
Mar 31, 2026 98.56 Mn
Dec 31, 2025 -441.37 Mn
Dec 31, 2025 -441.37 Mn
Sep 30, 2025 26.58 Mn
Sep 30, 2025 26.58 Mn
Jun 30, 2025 73.07 Mn
Jun 30, 2025 73.07 Mn
Mar 31, 2025 20.10 Mn
Mar 31, 2025 20.10 Mn
Dec 31, 2024 -26.62 Mn
Dec 31, 2024 -26.62 Mn
Sep 30, 2024 47.67 Mn
Sep 30, 2024 47.67 Mn
Jun 30, 2024 77.94 Mn
Jun 30, 2024 77.94 Mn
Mar 31, 2024 63.99 Mn
Mar 31, 2024 63.99 Mn
Dec 31, 2023 59.56 Mn
Dec 31, 2023 59.56 Mn